{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:35:39Z","timestamp":1781782539970,"version":"3.54.5"},"reference-count":76,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ejps.2008.12.010","type":"journal-article","created":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T09:33:58Z","timestamp":1230284038000},"page":"532-543","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacokinetic\u2013pharmacodynamic relationship of NRTIs and its connection to viral escape: An example based on zidovudine"],"prefix":"10.1016","volume":"36","author":[{"given":"Max","family":"von Kleist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Huisinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2008.12.010_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00003088-199630040-00001","article-title":"Clinical pharmacokinetics of zidovudine. An update.","volume":"30","author":"Acosta","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2008.12.010_bib2","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1097\/00002030-200310170-00003","article-title":"Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals","volume":"17","author":"Anderson","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2008.12.010_bib3","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/QAD.0b013e3282741feb","article-title":"Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults","volume":"21","author":"Anderson","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2008.12.010_bib4","doi-asserted-by":"crossref","first-page":"10968","DOI":"10.1016\/S0021-9258(19)49861-X","article-title":"Thymidine and 3\u2032-azido- 3\u2032-deoxythymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. A study of both anabolic and catabolic pathways","volume":"267","author":"Arn\u00e9r","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2008.12.010_bib5","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/JVI.70.2.712-720.1996","article-title":"Effects of 3\u2032-deoxynucleoside 5\u2032-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA","volume":"70","author":"Arts","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2008.12.010_bib6","doi-asserted-by":"crossref","unstructured":"Aweeka, F.T., Kang, M., Yu, J.-Y., Lizak, P., Alston, B., Chung, R.T., 5092s Study Team, A.I. D.S.C.T.G., 2007. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: Actg 5092s study team. HIV Med. 8, 288\u2013294.","DOI":"10.1111\/j.1468-1293.2007.00472.x"},{"key":"10.1016\/j.ejps.2008.12.010_bib7","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/00002030-199610000-00008","article-title":"The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites","volume":"10","author":"Barry","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2008.12.010_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/rcm.605","article-title":"Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral-blood mononuclear cells using high-performance liquid chromatography\/tandem mass spectrometry","volume":"16","author":"Becher","year":"2002","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ejps.2008.12.010_bib9","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/ac020144r","article-title":"Development of a direct assay for measuring intracellular AZT triphosphate in humans peripheral blood mononuclear cells","volume":"74","author":"Becher","year":"2002","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2008.12.010_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jtbi.2006.03.013","article-title":"Evolution on distributive lattices","volume":"242","author":"Beerenwinkel","year":"2006","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.ejps.2008.12.010_bib11","doi-asserted-by":"crossref","first-page":"47681","DOI":"10.1074\/jbc.M409627200","article-title":"Physiological roles of the intermediate conductance, Ca2+-activated potassium channel KCNN4","volume":"279","author":"Begenisich","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2008.12.010_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.0902-4441.2003.00199.x","article-title":"Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland","volume":"72","author":"Bisset","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejps.2008.12.010_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.med.53.082901.104024","article-title":"The challenge of viral reservoirs in HIV-1 infection","volume":"53","author":"Blankson","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejps.2008.12.010_bib14","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/JVI.75.10.4832-4842.2001","article-title":"Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase","volume":"75","author":"Boyer","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2008.12.010_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological parameter values for physiologically based pharmacokinetic models","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol. Ind. Health."},{"key":"10.1016\/j.ejps.2008.12.010_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/0091270002239821","article-title":"Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children","volume":"43","author":"Capparelli","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2008.12.010_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/BJ20041056","article-title":"Nucleotide specificity of HIV-1 reverse transcriptases with amino acid substitutions affecting Ala-114","volume":"387","author":"Cases-Gonz lez","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejps.2008.12.010_bib18","first-page":"412","article-title":"In vivo tissue disposition of 3\u2032-azido- 3\u2032-deoxythymidine and its anabolites in control and retrovirus-infected mice","volume":"25","author":"Chow","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2008.12.010_bib19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV drug resistance","volume":"350","author":"Clavel","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2008.12.010_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/jms.1176","article-title":"Improved method to quantify intracellular zidovudine mono- and triphosphate in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry","volume":"42","author":"Compain","year":"2007","journal-title":"J. Mass. Spectrom."},{"key":"10.1016\/j.ejps.2008.12.010_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/135965350400900216","article-title":"Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy","volume":"9","author":"Dixit","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejps.2008.12.010_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtbi.2003.09.002","article-title":"Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay","volume":"226","author":"Dixit","year":"2004","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.ejps.2008.12.010_bib23","doi-asserted-by":"crossref","unstructured":"Eilers, M., Roy, U., Mondal, D., 2008. Mrp (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells. Exp. Biol. Med. (Maywood).","DOI":"10.3181\/0802-RM-59"},{"key":"10.1016\/j.ejps.2008.12.010_bib24","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200009290-00010","article-title":"Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons","volume":"14","author":"Fletcher","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2008.12.010_bib25","doi-asserted-by":"crossref","unstructured":"Flynn, P.M., Rodman, J., Lindsey, J.C., Robbins, B., Capparelli, E., Knapp, K.M., Rodriguez, J.F., McNamara, J., Serchuck, L., Heckman, B., Martinez, J., the PACTG P1012 Team, 2007. Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents. Antimicrob. Agents Chemother. 51, 3516\u20133522.","DOI":"10.1128\/AAC.01626-06"},{"key":"10.1016\/j.ejps.2008.12.010_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0026-895X(25)11003-1","article-title":"Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3\u2032-azido- 3\u2032-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM)","volume":"37","author":"Fridland","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2008.12.010_bib27","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1073\/pnas.83.21.8333","article-title":"Phosphorylation of 3\u2032-azido- 3\u2032-deoxythymidine and selective interaction of the 5\u2032-triphosphate with human immunodeficiency virus reverse transcriptase","volume":"83","author":"Furman","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2008.12.010_bib28","unstructured":"Gail Skowron, M., Ogden, R. (Eds.), 2006. Reverse Transcriptase Inhibitors in HIV\/AIDS Therapy. Humana Press, Totowa, New Jersey."},{"key":"10.1016\/j.ejps.2008.12.010_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0026-895X(24)12179-7","article-title":"Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine","volume":"55","author":"Gao","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2008.12.010_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/clpt.1990.131","article-title":"Population pharmacokinetics of zidovudine. The veterans administration cooperative studies group","volume":"48","author":"Gitterman","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.12.010_bib31","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/sj.jcbfm.9600254","article-title":"HIV-tat protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier","volume":"26","author":"Hayashi","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2008.12.010_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0025-5564(03)00058-0","article-title":"Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity","volume":"184","author":"Huang","year":"2003","journal-title":"Math. Biosci."},{"key":"10.1016\/j.ejps.2008.12.010_bib33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/jac\/dkm353","article-title":"Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes","volume":"60","author":"Janneh","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2008.12.010_bib34","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/01.aids.0000194793.36175.40","article-title":"Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP","volume":"19","author":"Janneh","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2008.12.010_bib35","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.95.20.11514","article-title":"Drug concentration heterogeneity facilitates the evolution of drug resistance","volume":"95","author":"Kepler","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2008.12.010_bib36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.3016903","article-title":"Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy","volume":"233","author":"Koenig","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ejps.2008.12.010_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2165\/00003495-198937040-00003","article-title":"Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"37","author":"Langtry","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2008.12.010_bib38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm0897-922","article-title":"The bottleneck in AZT activation","volume":"3","author":"Lavie","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2008.12.010_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0166-3542(93)90032-E","article-title":"Intravascular distribution of zidovudine: role of plasma proteins and whole blood components","volume":"21","author":"Luzier","year":"1993","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejps.2008.12.010_bib40","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bcp.2006.01.003","article-title":"3\u2032-azido- 3\u2032-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity","volume":"71","author":"Lynx","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2008.12.010_bib41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1177\/0091270007307572","article-title":"Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products","volume":"47","author":"Marier","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2008.12.010_bib42","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1073\/pnas.86.2.675","article-title":"Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections","volume":"86","author":"McElrath","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2008.12.010_bib43","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/aid.1990.6.967","article-title":"Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease","volume":"6","author":"Meltzer","year":"1990","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.ejps.2008.12.010_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1468-1293.2007.00495.x","article-title":"Pharmacokinetics of oral zidovudine administered during labour: a preliminary study","volume":"8","author":"Mirochnick","year":"2007","journal-title":"HIV Med."},{"key":"10.1016\/j.ejps.2008.12.010_bib45","first-page":"97","article-title":"Intracellular pharmacokinetics of antiretroviral agents","volume":"9","author":"Owen","year":"2004","journal-title":"J. HIV Ther."},{"key":"10.1016\/j.ejps.2008.12.010_bib46","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2174\/1568026043388358","article-title":"Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase","volume":"4","author":"Painter","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejps.2008.12.010_bib47","doi-asserted-by":"crossref","unstructured":"Panhard, X., Legrand, M., Taburet, A.-M., Diquet, B., Goujard, C., Mentr\u00e9, F., the Cophar 1 ANRS 102 Study Group, 2007. Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART. Eur. J. Clin. Pharmacol. 63(11) 1019\u20131029","DOI":"10.1007\/s00228-007-0337-x"},{"key":"10.1016\/j.ejps.2008.12.010_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1137\/S0036144598335107","article-title":"Mathematical analysis of HIV-1 dynamics in vivo","volume":"41","author":"Perelson","year":"1999","journal-title":"SIAM Rev."},{"key":"10.1016\/j.ejps.2008.12.010_bib49","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1023\/A:1011956011207","article-title":"Intracellular phosphorylation of zidovudine (ZDV) and other nucleoside reverse transcriptase inhibitors (RTI) used for human immunodeficiency virus (HIV) infection","volume":"15","author":"Peter","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2008.12.010_bib50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","article-title":"Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy","volume":"18","author":"Pierson","year":"2000","journal-title":"Annu. Rev. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejps.2008.12.010_bib51","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/01.qai.0000137001.40505.56","article-title":"Pharmacokinetic properties of nucleoside\/nucleotide reverse transcriptase inhibitors.","volume":"37","author":"Piliero","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ejps.2008.12.010_bib52","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1063\/1.1545446","article-title":"Stochastic chemical kinetics and the quasi-steady-state assumption: Application to the Gillespie algorithm","volume":"118","author":"Rao","year":"2003","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejps.2008.12.010_bib53","first-page":"185","article-title":"Langerhans\u2019 cells are an actual site of HIV-1 replication","volume":"29","author":"Rappersberger","year":"1988","journal-title":"Intervirology"},{"key":"10.1016\/j.ejps.2008.12.010_bib54","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1021\/bi034435l","article-title":"Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis","volume":"42","author":"Ray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2008.12.010_bib55","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35073673","article-title":"HIV chemotherapy","volume":"410","author":"Richman","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2008.12.010_bib56","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/infdis\/174.3.490","article-title":"A systemic and cellular model for zidovudine plasma concentrations and intracellular phosphorylation in patients","volume":"174","author":"Rodman","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejps.2008.12.010_bib57","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.clpt.2005.07.010","article-title":"A pharmacokinetic\u2013pharmacodynamic disease model to predict in vivo antiviral activity of maraviroc","volume":"78","author":"Rosario","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.12.010_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1592\/phco.24.4.307.33184","article-title":"Pharmacodynamic effects of zidovudine 600mg once\/day versus 300mg twice\/day in therapy-na\u00efve patients infected with human immunodeficiency virus","volume":"24","author":"Ruane","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejps.2008.12.010_bib59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.280.1.67","article-title":"Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy","volume":"280","author":"Schrager","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ejps.2008.12.010_bib60","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.clinthera.2008.05.003","article-title":"Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy brazilian volunteers: An open-label, randomized, single-dose, two-way crossover study","volume":"30","author":"Serra","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2008.12.010_bib61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00042560-199708010-00006","article-title":"A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease","volume":"15","author":"Shepp","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.ejps.2008.12.010_bib62","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra032395","article-title":"Where does HIV live?","volume":"350","author":"Stebbing","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2008.12.010_bib63","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/0190-9622(90)70165-E","article-title":"Langerhans cells in HIV-1 infection","volume":"22","author":"Stingl","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2008.12.010_bib64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00007691-199107000-00008","article-title":"Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations","volume":"13","author":"Stretcher","year":"1991","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2008.12.010_bib65","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.aids.0000168968.34810.ca","article-title":"Antiretroviral therapies for treatment-experienced patients: current status and research challenges","volume":"19","author":"Struble","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2008.12.010_bib66","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/AAC.01227-06","article-title":"Zidovudine inhibits thymidine phosphorylation in the isolated perfused rat heart","volume":"51","author":"Susan-Resiga","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2008.12.010_bib67","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0006-2952(94)00453-S","volume":"49","author":"T\u00f6rnevik","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2008.12.010_bib68","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0003-2697(91)90470-E","article-title":"A sensitive nonisotopic method for the determination of intracellular azidothymidine 5\u2032-mono-, 5\u2032-di-, and 5\u2032-triphosphate","volume":"196","author":"Toyoshima","year":"1991","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2008.12.010_bib69","doi-asserted-by":"crossref","unstructured":"Tozzi, V., Zaccarelli, M., Bonfigli, S., Lorenzini, P., Liuzzi, G., Trotta, M.P., Forbici, F., Gori, C., Bertoli, A., Bellagamba, R., Narciso, P., Perno, C.F., Antinori, A., for Clinical Use of HIV Genotype Resistance Test, C.G., 2006. Drug-class-wide resistance to antiretrovirals in hiv-infected patients failing therapy: prevalence, risk factors and virological outcome. Antivir Ther. 11, 553\u2013560.","DOI":"10.1177\/135965350601100503"},{"key":"10.1016\/j.ejps.2008.12.010_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00928361","article-title":"Physiological concentrations of purines and pyrimidines","volume":"140","author":"Traut","year":"1994","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejps.2008.12.010_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1523-1747.ep12525402","article-title":"Epidermal langerhans cells\u2013a target for HTLV-III\/LAV infection","volume":"88","author":"Tschachler","year":"1987","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2008.12.010_bib72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.compbiolchem.2004.05.001","article-title":"Stochastic approaches for modelling in vivo reactions","volume":"28","author":"Turner","year":"2004","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejps.2008.12.010_bib73","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1128\/AAC.44.7.1986-1989.2000","article-title":"Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteers","volume":"44","author":"Wattanagoon","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2008.12.010_bib74","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkl474","article-title":"Modulation of human BCRP (ABCG2) activity by anti-HIV drugs","volume":"59","author":"Weiss","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2008.12.010_bib75","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003495-199346030-00010","article-title":"Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"46","author":"Wilde","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2008.12.010_bib76","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1016\/S0021-9258(18)45638-4","article-title":"3\u2032-azido- 3\u2032-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion","volume":"262","author":"Zimmerman","year":"1987","journal-title":"J. Biol. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708004892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708004892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T11:49:57Z","timestamp":1738842597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098708004892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":76,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0928098708004892"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2008.12.010","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}